canin
infecti
respiratori
diseas
cird
major
caus
morbid
dog
worldwid
associ
number
new
emerg
pathogen
larg
multicentr
european
studi
preval
four
key
emerg
cird
pathogen
canin
respiratori
coronaviru
crcov
canin
pneumoviru
cnpnv
influenza
mycoplasma
cyno
cyno
estim
risk
factor
exposur
infect
clinic
diseas
investig
cird
affect
dog
studi
includ
pet
kennel
dog
diseas
occurr
sever
significantli
reduc
dog
vaccin
classic
cird
agent
canin
distemp
viru
cdv
canin
adenoviru
canin
parainfluenza
viru
cpiv
substanti
proport
vaccin
dog
remain
affect
crcov
cnpnv
highli
preval
across
differ
dog
popul
overal
seroposit
detect
rate
crcov
cnpnv
respect
presenc
associ
increas
occurr
sever
clinic
diseas
antibodi
crcov
protect
effect
crcov
infect
sever
clinic
sign
cird
antibodi
cnpnv
involv
cyno
influenza
cird
less
appar
despit
dog
seroposit
cyno
pcr
posit
cyno
dog
seroposit
influenza
none
posit
pcr
canin
adenoviru
type
ditchfield
et
al
bordetella
bronchiseptica
bb
bemi
act
sequenti
synergist
caus
diseas
sever
multival
vaccin
target
agent
avail
routin
vaccin
day
et
al
howev
outbreak
respiratori
diseas
continu
despit
use
result
expens
treatment
cost
delay
rehom
train
erl
et
al
recent
year
number
newli
emerg
pathogen
includ
canin
respiratori
coronaviru
crcov
erl
et
al
canin
pneumoviru
cnpnv
renshaw
et
al
canin
influenza
civ
crawford
et
al
mycoplasma
cyno
cyno
chalker
et
al
implic
develop
persist
cird
subject
comprehens
review
priestnal
et
al
whilst
wide
recognis
agent
like
play
import
role
onset
persist
cird
exact
natur
contribut
pathogenesi
diseas
yet
determin
studi
date
either
limit
investig
individu
pathogen
geograph
restrict
small
number
kennel
singl
outbreak
comprehens
survey
pet
dog
complet
thu
true
extent
preval
novel
agent
risk
factor
associ
exposur
infect
diseas
amongst
differ
cohort
fulli
investig
help
address
present
data
larg
multicentr
european
studi
preval
four
import
recent
identifi
emerg
cird
pathogen
crcov
cnpnv
civ
influenza
cyno
estim
clientown
kenneld
dog
risk
factor
exposur
infect
clinic
diseas
investig
sampl
signal
data
collect
dog
anim
shelter
breed
kennel
academ
privat
veterinari
clinic
across
europ
collabor
investig
centr
octob
august
dog
activ
recruit
onto
studi
sampl
upon
present
veterinarian
fell
one
three
differ
clinic
group
clinic
unaffect
expos
acut
cirdaffect
dog
b
acut
cirdaffect
dog
day
post
onset
cird
c
convalesc
cirdaffect
dog
day
post
onset
cird
detail
clinic
group
sourc
ie
clientown
shelterrehom
kennel
hospit
breed
kennel
record
estim
age
vaccin
histori
bb
cpiv
cdv
clinic
respiratori
score
time
sampl
collect
record
briefli
clinic
score
describ
previous
erl
et
al
defin
respiratori
sign
mild
cough
cough
nasal
discharg
cough
nasal
discharg
depress
inappet
cough
nasal
discharg
depress
andor
inappet
clinic
sign
lower
respiratori
tract
diseas
viral
nasal
swab
vn
sterilin
uk
oropharyng
ami
swab
oa
sterilin
uk
serum
sampl
collect
local
veterinari
practition
sampl
collect
part
standard
veterinari
diagnost
workup
respiratori
diseas
inform
consent
clinic
research
purpos
obtain
attend
veterinarian
collabor
centr
sampl
sent
investig
centr
across
europ
appropri
store
batch
ship
royal
veterinari
colleg
analysi
duplic
sampl
retain
collabor
investig
centr
research
purpos
date
one
studi
relat
subset
publish
decaro
et
al
studi
approv
royal
veterinari
colleg
ethic
review
board
tip
vn
immers
ml
dmem
medium
sigma
dorset
uk
vigor
mix
rna
extract
result
swab
fluid
use
rneasi
mini
kit
qiagen
crawley
uk
recommend
manufactur
elut
rnase
free
water
five
microlit
rna
revers
transcrib
cdna
use
random
hexamer
qiagen
crawley
uk
improm
ii
revers
transcriptas
promega
southampton
uk
accord
manufactur
protocol
crcov
cnpnv
detect
describ
previous
pcr
erl
et
al
realtim
pcr
mitchel
et
al
respect
influenza
detect
use
primer
target
conserv
region
matrix
gene
elli
zambon
gotaq
polymeras
system
promega
southampton
uk
tip
oa
place
ml
mycoplasma
experi
liquid
media
mycoplasma
experi
ltd
bletchingley
uk
vigor
mix
incub
co
cultur
monitor
daili
day
sign
mycoplasma
growth
indic
presenc
turbid
colour
chang
growth
observ
day
post
inocul
appar
growth
cell
ml
liquid
cultur
pellet
dna
extract
use
dneasi
mini
kit
qiagen
crawley
uk
recommend
manufactur
dna
elut
elut
buffer
analys
use
panmycoplasma
spp
pcr
kobayashi
et
al
follow
specif
cyno
pcr
chalker
et
al
previous
describ
antibodi
statu
dog
crcov
cnpnv
cyno
determin
elisa
use
follow
antigen
recombin
crcov
hemagglutinin
esteras
protein
crcov
protein
strain
express
use
recombin
baculoviru
express
system
merck
uk
spodoptera
frugiperda
cell
antigen
prepar
lyse
infect
cell
lysi
buffer
igep
mm
nah
po
mm
nacl
day
post
infect
crcov
antigen
standardis
mock
infect
lysat
serv
control
antigen
microgram
total
protein
per
well
use
coat
plate
freezedri
murin
pneumoviru
control
antigen
churchil
appli
biotechnolog
ltd
huntingdon
prepar
use
describ
previous
mitchel
et
al
cyno
uk
strain
cell
pellet
wash
three
time
pb
resuspend
ml
pb
freez
thaw
six
nanogram
per
well
total
cyno
protein
pb
use
coat
plate
well
coat
pb
use
background
control
antigen
adsorb
overnight
onto
well
nunc
elisa
plate
block
milk
pb
tween
serum
sampl
dilut
block
buffer
dispens
duplic
onto
posit
control
antigen
incub
h
follow
three
wash
pbst
antidog
igg
peroxidas
conjug
sigmaaldrich
pool
secondari
antibodi
dilut
crcov
cnpnv
cyno
block
buffer
dispens
well
incub
plate
wash
bound
antibodi
detect
use
opd
peroxidas
substrat
sigma
aldrich
uk
accord
manufactur
instruct
stop
h
optic
densiti
od
measur
nm
optimax
automat
plate
reader
molecular
devic
wokingham
posit
neg
control
sera
includ
duplic
plate
serum
sampl
averag
od
valu
neg
antigen
subtract
posit
antigen
give
averag
correct
od
valu
posit
cutoff
defin
averag
correct
od
valu
panel
refer
serum
igg
neg
antigen
use
plu
three
time
standard
deviat
sampl
consid
posit
averag
correct
od
valu
greater
equal
posit
cutoff
valu
elisa
influenza
antibodi
statu
determin
via
two
independ
method
freezedri
equin
influenza
miami
control
antigen
churchil
appli
b
biotechnolog
ltd
huntingdon
use
accord
manufactur
recommend
valid
use
canin
sampl
use
panel
civ
posit
neg
control
serum
zoeti
anim
health
kalamazoo
elisa
perform
describ
use
dilut
secondari
antibodi
commerci
avail
id
screen
influenza
antibodi
competit
assay
assay
perform
accord
manufactur
protocol
use
dilut
canin
serum
previous
describ
pratelli
colao
assay
valid
use
control
suppli
kit
panel
civ
posit
neg
control
serum
zoeti
anim
health
kalamazoo
data
record
excel
spreadsheet
microsoft
import
statas
softwar
statacorp
analysi
continu
variabl
summaris
use
mean
standard
deviat
normal
distribut
median
minimum
maximum
nonnorm
distribut
categor
variabl
summaris
use
number
percent
categori
confid
interv
ci
around
preval
estim
calcul
use
clopperpearson
method
purpos
analys
clinic
score
variabl
collaps
origin
categoris
detail
threepoint
sever
score
diseas
clinic
score
mild
moder
diseas
clinic
score
sever
diseas
clinic
score
presenc
absenc
diseas
also
assess
origin
clinic
score
indic
presenc
diseas
indic
diseas
variat
diseas
presenc
sever
differ
factor
sourc
age
countri
vaccin
statu
variat
individu
pathogen
preval
seropreval
associ
sourc
clinic
group
diseas
presenc
sever
examin
use
chisquarefish
exact
test
univari
logist
regress
multivari
logist
regress
use
examin
relationship
one
factor
significantli
associ
outcom
level
univari
screen
pvalu
descript
statist
relat
dog
sampl
includ
mitchel
et
al
veterinari
microbiolog
studi
summaris
tabl
sampl
signal
data
obtain
dog
tabl
n
clientown
dog
n
shelter
n
sourc
predominantli
singl
veterinari
hospit
overal
n
clinic
unaffect
dog
expos
acut
cirdaffect
dog
n
acut
cirdaffect
dog
n
convalesc
day
post
onset
acut
diseas
may
may
still
show
clinic
sign
cird
approxim
equal
proport
sampl
came
itali
greec
hungari
franc
respect
smaller
proport
spain
netherland
estim
age
record
dog
rang
week
year
median
year
clinic
sign
respiratori
diseas
observ
n
dog
half
dog
n
show
sign
mild
moder
diseas
n
show
sign
sever
diseas
total
serum
sampl
examin
presenc
crcov
cnpnv
influenza
mcyno
antibodi
viral
nasal
swab
vn
oropharyng
ami
swab
oa
analys
presenc
pathogen
overal
estim
seropreval
studi
popul
overal
estim
preval
pathogen
detect
pcr
ci
crcov
ci
cnpnv
n
ci
cyno
influenza
signific
univari
variat
presenc
sever
diseas
associ
sourc
countri
vaccin
age
data
shown
dog
clinic
sign
significantli
younger
median
year
rang
week
year
without
median
year
rang
week
year
p
invers
relationship
age
diseas
sever
whilst
clinic
diseas
clearli
preval
amongst
dog
without
histori
vaccin
bb
cpiv
cdv
odd
diseas
significantli
reduc
dog
vaccin
cpiv
cdv
bb
variat
diseas
presenc
associ
countri
age
longer
signific
multivari
analysi
howev
reduc
odd
diseas
remain
significantli
associ
histori
vaccin
cpiv
cdv
independ
effect
reduc
odd
diseas
shelter
dog
dog
sourc
compar
clientown
dog
tabl
examin
vaccin
effect
indic
proport
dog
histori
vaccin
cpiv
cdv
reduc
significantli
sever
diseas
increas
fig
signific
variat
pathogen
seropreval
associ
countri
sourc
age
antibodi
statu
clinic
group
vari
pathogen
studi
signific
univari
variat
crcov
seropreval
detect
countri
age
sourc
diseas
statu
clinic
score
cnpnv
seroposit
data
shown
dog
antibodi
crcov
significantli
less
like
develop
respiratori
diseas
p
odd
ratio
p
p
dog
clinic
score
respect
compar
dog
clinic
sign
follow
multivari
analysi
independ
effect
countri
age
cnpnv
antibodi
statu
remain
signific
tabl
dog
franc
spain
significantli
increas
odd
seroposit
p
p
respect
compar
dog
itali
dog
also
significantli
like
crcov
seroposit
increas
age
p
also
seroposit
cnpnv
p
signific
univari
variat
cnpnv
seropreval
detect
countri
sourc
clinic
group
diseas
statu
clinic
score
data
shown
dog
antibodi
cnpnv
significantli
less
like
develop
respiratori
diseas
without
p
odd
ratio
p
p
dog
clinic
score
respect
compar
clinic
sign
diseas
multivari
analysi
independ
effect
countri
sourc
crcov
cyno
antibodi
statu
remain
signific
tabl
dog
franc
netherland
p
p
time
odd
seroposit
compar
dog
itali
dog
shelter
almost
time
p
dog
sourc
time
p
like
cnpnv
seroposit
clientown
dog
odd
cnpnv
seroposit
also
significantli
increas
associ
crcov
p
cyno
p
seroposit
signific
univari
variat
mcyno
seropreval
detect
associ
countri
sourc
clinic
group
crcov
cnpnv
antibodi
statu
signific
associ
cyno
antibodi
statu
presenc
sever
clinic
diseas
observ
data
shown
independ
effect
countri
sourc
clinic
group
age
remain
signific
multivari
analysi
tabl
dog
greec
franc
spain
p
p
p
time
like
seroposit
cyno
itali
respect
shelter
dog
almost
twice
like
pet
dog
seroposit
cyno
p
convalesc
dog
almost
three
time
like
seroposit
clinic
unaffect
expos
dog
p
odd
cyno
seroposit
also
increas
age
p
overal
seropreval
influenza
ci
good
correl
two
elisa
protocol
use
small
number
seroposit
dog
preclud
statist
analysi
howev
six
posit
dog
five
shelter
one
clientown
three
acut
mild
sign
clinic
diseas
two
convalesc
clinic
sign
diseas
one
healthi
expos
signific
variat
pathogen
presenc
associ
countri
sourc
clinic
score
antibodi
statu
vari
pathogen
studi
signific
univari
variat
crcov
presenc
detect
countri
age
clinic
score
crcov
cnpnv
seroposit
data
shown
independ
associ
countri
clinic
score
presenc
crcov
antibodi
remain
signific
multivari
analysi
tabl
dog
greec
p
hungari
p
franc
p
spain
p
significantli
increas
odd
crcov
posit
compar
dog
itali
dog
sever
clinic
sign
time
like
posit
crcov
sign
clinic
diseas
p
almost
half
like
posit
crcov
antibodi
viru
p
signific
univari
variat
cnpnv
presenc
detect
countri
sourc
clinic
score
presenc
absenc
cnpnv
antibodi
data
shown
independ
effect
countri
clinic
score
crcov
statu
remain
signific
multivari
analysi
tabl
dog
hungari
p
twice
odd
cnpnv
posit
dog
itali
presenc
crcov
associ
twofold
increas
odd
cnpnv
presenc
p
dog
sever
clinic
diseas
twice
odd
cnpnv
posit
clinic
diseas
p
overal
n
ci
dog
posit
mycoplasma
spp
n
ci
posit
cyno
data
shown
small
number
cyno
posit
dog
n
preclud
analysi
howev
four
shelter
dog
one
clientown
three
sever
respiratori
sign
one
requir
euthanasia
whilst
two
dog
nonclin
trachea
lung
bronchial
lymph
node
palatin
tonsil
thymu
euthan
dog
analys
except
lung
posit
cyno
none
dog
screen
presenc
influenza
pcr
posit
data
shown
studi
examin
occurr
cird
four
import
emerg
pathogen
associ
diseas
differ
dog
popul
across
europ
key
variabl
eg
clinic
present
hous
vaccin
etc
relationship
diseas
occurr
sever
pathogen
exposur
presenc
also
analys
overal
clinic
diseas
occur
approxim
twothird
dog
variat
rate
occurr
sever
predominantli
associ
hous
vaccin
histori
whilst
cird
gener
regard
diseas
kennel
dog
shown
also
provid
substanti
evid
cird
pet
clientown
dog
mani
moder
sever
sign
diseas
highlight
need
consider
pet
dog
occurr
spread
cird
potenti
risk
factor
associ
group
eg
multidog
household
attend
dog
train
doggi
day
care
recent
board
kennel
howev
high
rate
cird
observ
clientown
dog
compar
kennel
dog
like
explain
inher
sampl
bia
healthi
clientown
dog
unlik
present
sampl
part
normal
veterinari
investig
except
case
multidog
household
doggi
day
care
etc
cird
problemat
contrast
sampl
appar
healthi
dog
kennel
environ
often
form
part
standard
outbreak
investig
vaccin
therefor
like
biggest
influenc
occurr
sever
diseas
studi
within
eu
recommend
dog
routin
vaccin
cdv
part
core
vaccin
receiv
puppyhood
modifiedl
viru
vaccin
administ
parenter
highli
efficaci
day
et
al
core
vaccin
formul
includ
cpiv
bb
whilst
separ
modifiedl
intranas
vaccin
bb
cpiv
availa
tend
administ
high
risk
dog
ie
period
kennel
studi
cpiv
bb
vaccin
efficaci
regul
european
monograph
requir
specif
efficaci
safeti
requirmemnt
includ
onset
durat
immun
howev
publish
studi
limit
debat
differ
efficaci
demonstr
day
et
al
elli
elli
krakowka
mitchel
brownli
histori
vaccin
classic
cirdassoci
pathogen
cdv
cpiv
significantli
reduc
occurr
sever
diseas
howev
vaccin
bb
although
could
due
small
number
bb
vaccin
dog
n
studi
despit
evid
protect
effect
substanti
proport
cdv
cpiv
vaccin
dog
remain
affect
cird
mani
sever
clinic
sign
support
wide
accept
view
vaccin
key
agent
may
reduc
diseas
occurr
sever
individu
outbreak
often
poorli
effect
other
differ
may
result
vaccin
formul
protocol
use
biolog
properti
characterist
agent
host
involv
newli
identifi
emerg
pathogen
erl
et
al
priestnal
et
al
whilst
first
two
point
fall
beyond
scope
studi
examin
four
import
emerg
cird
pathogen
clear
role
cird
may
signific
kennel
pet
dog
particular
crcov
cnpnv
highli
preval
across
differ
dog
popul
studi
presenc
posit
associ
increas
occurr
sever
clinic
diseas
presenc
involv
cyno
influenza
cird
howev
less
appar
almost
half
dog
studi
seroposit
crcov
posit
viru
consist
publish
data
erl
et
al
priestnal
et
al
multivari
analysi
show
likelihood
dog
antibodi
crcov
increas
age
antibodi
significantli
less
like
posit
viru
dog
increas
diseas
sever
significantli
like
posit
crcov
dog
antibodi
crcov
develop
cird
less
like
develop
sever
clinic
sign
diseas
younger
dog
less
like
antibodi
crcov
like
infect
crcov
greater
rate
occurr
cird
develop
sever
clinic
sign
find
consist
previous
publish
data
erl
et
al
erl
et
al
mitchel
et
al
strengthen
evid
causal
relationship
crcov
infect
cird
well
protect
effect
crcov
antibodi
crcov
infect
clinic
sign
cird
gener
whilst
evid
crcov
pet
dog
report
previous
mochizuki
et
al
priestnal
et
al
first
studi
link
infect
clinic
diseas
group
compar
crcov
similar
overal
level
cnpnv
seroposit
higher
detect
rate
cnpnv
observ
consist
publish
data
mitchel
et
al
antibodi
cnpnv
detect
dog
three
sourc
demonstr
suscept
pet
kennel
dog
viru
although
shelter
dog
dog
sourc
significantli
increas
odd
posit
compar
pet
dog
higher
seroprevelc
observ
dog
sourc
like
due
sampl
deriv
predominantli
outbreak
cird
singl
veterinari
hospit
dog
seroposit
posit
viru
dog
significantli
like
cnpnv
seroposit
also
seroposit
crcov
vice
versa
cyno
suggest
frequent
coinfect
cocircul
one
pathogen
support
dog
significantli
like
posit
cnpnv
pcr
also
posit
crcov
pcr
although
case
observ
studi
preclud
analysi
cird
increasingli
consid
complex
infect
multipl
agent
act
sequenti
synergist
caus
diseas
similar
diseas
complex
human
subject
sever
review
eg
bosch
et
al
like
therefor
coinfect
classic
novel
agent
cird
contribut
increas
likelihood
diseas
onset
sever
durat
cird
given
limit
amount
work
field
current
address
point
howev
import
focu
futur
dog
increas
diseas
sever
significantli
like
posit
cnpnv
support
causal
relationship
cird
glineur
et
al
mitchel
et
al
follow
multivari
analysi
signific
relationship
presenc
cnpnv
antibodi
infect
diseas
occurr
observ
relationship
howev
signific
univari
level
consist
publish
data
mitchel
et
al
suggest
whilst
cnpnv
specif
antibodi
may
confer
degre
protect
confound
instanc
effect
factor
said
well
document
antibodi
mediat
immun
relat
human
bovin
respiratori
syncyti
virus
poor
individu
may
repeatedli
reinfect
throughout
lifetim
clinic
sign
respiratori
diseas
falsey
hall
et
al
van
der
poel
et
al
number
key
pneumoviru
featur
enabl
evad
modifi
host
immun
respons
reviw
collin
melero
would
vital
assess
genet
antigen
divers
circul
cnpnv
strain
better
understand
cnpnv
ecolog
inform
vaccin
design
develop
although
studi
limit
cyno
also
repres
potenti
import
agent
develop
persist
cird
chalker
et
al
rosend
first
studi
examin
seropreval
cyno
overal
dog
seroposit
compar
crcov
cnpnv
multivari
analysi
increas
odd
cyno
seroposit
seen
shelter
dog
compar
pet
dog
convalesc
compar
clinic
unaffect
dog
age
whilst
seroposit
suggest
exposur
dog
cyno
n
detect
three
sever
respiratori
sign
two
clinic
unaffect
given
limit
number
posit
case
studi
possibl
comment
preval
cyno
relationship
clinic
diseas
howev
worth
consid
limit
studi
may
influenc
find
firstli
sever
mycoplasma
speci
carri
dog
often
part
normal
respiratori
flora
chalker
howev
limit
data
avail
regard
serolog
crossreact
rosend
possibl
exist
therefor
use
whole
cell
elisa
antigen
studi
may
result
overestim
cyno
seroposit
secondli
oropharyng
swab
collect
part
standard
veterinari
investig
cird
analys
previous
respiratori
tissu
shown
yield
much
higher
recoveri
rate
cyno
compar
oropharyng
swab
chalker
et
al
inde
studi
implic
cyno
cird
base
tissu
sampl
particularli
lower
respiratori
tract
zeugswett
et
al
level
cyno
detect
studi
may
therefor
vastli
underestim
highlight
import
consider
studi
cyno
live
dog
influenza
caus
signific
respiratori
diseas
dog
north
america
anderson
et
al
crawford
et
al
estim
seropreval
high
risk
popul
anderson
et
al
subsequ
studi
north
central
america
asia
also
identifi
number
influenza
subtyp
infect
caus
diseas
dog
undergon
crossspeci
transmiss
includ
possibl
transmiss
dog
human
lin
et
al
song
et
al
song
et
al
songserm
et
al
assay
therefor
select
basi
would
allow
broad
detect
influenza
rather
specif
subtyp
damiani
et
al
elli
zambon
agreement
recent
publish
european
studi
damiani
et
al
dundon
et
al
howev
littl
evid
influenza
found
studi
dog
neg
influenza
pcr
evid
exposur
via
antibodi
detect
whilst
influenza
appear
rel
insignific
european
dog
popul
present
given
rapid
spread
across
north
america
asia
increas
number
influenza
subtyp
detect
dog
increas
movement
dog
across
europ
may
matter
time
make
appear
moreov
coexist
multipl
type
influenza
dog
potenti
crossspeci
underlin
import
continu
vigil
veterinari
medic
commun
current
understand
true
preval
complex
cird
limit
lack
comprehens
investig
caus
agent
associ
risk
factor
studi
begun
unpick
key
area
one
largest
studi
undertaken
field
date
find
highlight
need
far
greater
consider
pet
dog
dog
popul
role
current
vaccin
formul
strategi
prevent
manag
diseas
outbreak
impact
classic
newli
identifi
pathogen
diseas
onset
develop
persist
pathogen
crcov
cnpnv
emerg
data
provid
clearli
identifi
link
cird
howev
continu
effort
requir
characteris
epidemiolog
pathogenesi
elus
pathogen
cyno
ensur
underestim
overlook
